AMEX · Dividend

Stereotaxis, Inc. (STXS) Dividend

$0.88 AMEX: STXS Market Cap $88.39M

Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)

MetricValue
Dividend YieldNone
Indicated Annual Dividend—
Payout Ratio—
FCF Yield-18.35%
Current Price$0.88

Dividend Analysis

Stereotaxis, Inc. (STXS) does not currently pay a dividend, based on the latest available data. Companies that do not pay dividends may use earnings for reinvestment, acquisitions, share buybacks, or debt repayment instead.

Free cash flow yield of -18.35% is below the 0.00% dividend yield, so the dividend is not fully covered by free cash flow at the current price.

Dividend yield against peers

Stereotaxis, Inc. has the lowest dividend yield of the 9 companies compared here.

CompanyYieldP/EPrice
Becton, Dickinson and Company (BDX)2.01%50.89$215.42
West Pharmaceutical Services, Inc. (WST)0.26%45.37$414.12
Baxter International Inc. (BAX)0.16%—$25.76
Medline Inc. (MDLN)0.00%62.75$37.68
Solventum Corporation (SOLV)0.00%99.57$86.06
The Cooper Companies, Inc. (COO)0.00%20.32$60.72
Repligen Corporation (RGEN)0.00%—$162.18
Avantor, Inc. (AVTR)0.00%31.15$15.18
Stereotaxis, Inc. (STXS)0.00%-3.46$0.88

Stereotaxis, Inc. (STXS) dividend — frequently asked questions

Does Stereotaxis, Inc. (STXS) pay a dividend?

No, Stereotaxis, Inc. (STXS) does not currently pay a dividend.

Dividend yields of other Medical - Instruments & Supplies stocks

BDX yield 2.01%WST yield 0.26%BAX yield 0.16%ATR yield 1.39%All Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
STXS Overview STXS Financials Screen Dividend Stocks

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.